RUNX1/CD44 axis regulates the proliferation, migration, and immunotherapy of gliomas: A single-cell sequencing analysis.

Hao Zhang,Hui Cao,Hong Luo,Nan Zhang,Zeyu Wang,Ziyu Dai,Wantao Wu,Guodong Liu,Zongyi Xie,Quan Cheng,Yuan Cheng

Frontiers in immunology（2023）

引用 0|浏览20

暂无评分

摘要

Therefore, CD44 was responsible for glioma growth and progression. It could potentially lead to a novel target for glioma immunotherapy or a prognostic biomarker.

查看译文

关键词

CD44,PD-L1,RUNX1,glioma,immunotherapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要